Effect of epidermal growth factor therapy on scar formation after cesarean section

Effect of topical epidermal growth factor therapy on hypertrophic scar formation after cesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003553

Enrollment

Registered

2019-02-25

Start date

2019-05-13

Completion date

Unknown

Last updated

2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Apply EGF ointment 10g for experimental group, and placebo 10g for control group on operating wound area at right after operation, and post operating date 1,2,3. Apply the Ointment once a day,

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients aged between 19-50 and undergo cesarean section at the Seoul St. Mary's Hospital during study period 2. Regardless of past cesarean section history or presence of keloid scar, patients who are not applicable to exclusion criteria below.

Exclusion criteria

Exclusion criteria: 1. Except keloid scar from past cesarean section operation, presence of any other skin lesions on incision site. 2. Adverse effect history of this medicine or Analogies.

Design outcomes

Primary

Measure	Time frame
degree of hypertrophic scar	—

Countries

Korea, Republic of

Contacts

Public ContactWoo Jeng Kim

The Catholic University of Korea, Seoul St. Mary's Hospital

yoteamo811@naver.com+82-2-2258-3023

Outcome results